Aavantgarde Presents Safety Data Of The First Two Subjects Dosed In The LUCE-1 Study, Evaluating AAVB-081 (Dual-AAV) In Retinitis Pigmentosa Related To Usher Syndrome Type 1B At Floretina 2024

(MENAFN - GlobeNewsWire - Nasdaq) MILAN, Dec. 09, 2024 (GLOBE NEWSWIRE) -- AAVantgarde Bio (AAVantgarde), an Italy-based global biotechnology company, presented preliminary safety data on the first ...Ads Links by Easy Branches
Play online games for free at games.easybranches.com

Guest Post Services www.easybranches.com/contribute